New Study Proposes Resilience Approach for HBV Disease Diagnosis Via Blood Tests
A team of researchers developed a new cost-effective method to diagnose and predict HBV-related diseases based on blood tests.
Read MorePosted by Andy Lundin | Sep 28, 2023 | Infectious Diseases |
A team of researchers developed a new cost-effective method to diagnose and predict HBV-related diseases based on blood tests.
Read MorePosted by Andy Lundin | Sep 28, 2023 | Company News, Microarray Systems |
Yamaha Motor established a new medical company that will analyze the antibodies in blood to better visualize people’s health conditions.
Read MorePosted by Andy Lundin | Sep 27, 2023 | Gastrointestinal Infections, Immunoassay Reagents & test Kits |
The U.S. FDA cleared the chromogranin A test and immunoassay for the assessment of tumor progression in GEP-NET patients.
Read MorePosted by Chris Wolski | Sep 26, 2023 | Sepsis |
Steripath delivers critical time savings for sepsis diagnosis, improving patient outcomes and providing cost efficiencies.
Read MorePosted by Andy Lundin | Sep 25, 2023 | Company News |
Dante Genomics announced a strategic AI collaboration with AWS to bring generative AI to the clinical care of patients with genomic diseases.
Read More